Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Small Cell Lung Carcinoma 42Ovarian Neoplasms 33Fallopian Tube Neoplasms 15Neoplasms 12Carcinoma, Ovarian Epithelial 10Uterine Cervical Neoplasms 7Recurrence 6Neuroblastoma 5Lung Neoplasms 5Neoplasm Metastasis 4Carcinoma, Non-Small-Cell Lung 4Sarcoma, Ewing 3Endometrial Neoplasms 3Uterine Cervical Dysplasia 2Sarcoma, Clear Cell 2Sarcoma 2Rhabdomyosarcoma 2Myoepithelioma 2Medulloblastoma 2Liposarcoma, Myxoid 2Histiocytoma, Angiomatoid Fibrous 2Hereditary Sensory and Autonomic Neuropathies 2Diffuse Intrinsic Pontine Glioma 2Desmoplastic Small Round Cell Tumor 2Chondrosarcoma, Extraskeletal Myxoid 2Carcinoma 2Solid Tumours 1Solid Tumors 1Solid Tumor 1SCLC 1

Interventions

Trastuzumab 209Paclitaxel 187Fulvestrant 161Capecitabine 150Docetaxel 136Letrozole 127exemestane 92palbociclib 76Anastrozole 75Cyclophosphamide 71Lapatinib 69Gemcitabine 66Bevacizumab 66pertuzumab 61pembrolizumab 60ribociclib 59Carboplatin 59abemaciclib 53eribulin 48Doxorubicin 45Vinorelbine 41Everolimus 41Ado-Trastuzumab Emtansine 41Tamoxifen 40130-nm albumin-bound paclitaxel 34Injections 31trastuzumab deruxtecan 30Albumin-Bound Paclitaxel 26olaparib 24Alpelisib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Breast Neoplasms × Topotecan × Clear all
NCT00437073 2015-10-15

Brain Metastases In ErbB2-Positive Breast Cancer

GlaxoSmithKline

Phase 2 Terminated
22 enrolled 8 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡